1.1 | Scope Of The Study |
1.2 | Research Methodology |
1.2.1 | Overall Market Estimation And Forecast |
1.2.2 | Bis Research Methodology |
1.3 | Report Description |
A quick peek into the report
Table of Contents
RESEARCH METHODOLOLOGY, SCOPE AND COVERAGE
EXECUTIVE SUMMARY
2.1 | EXECUTIVE SUMMARY |
INTRODUCTION TO NORTH AMERICAN CANNABIS MARKET
3.1 | Cannabis Market Evolution And Trend |
3.2 | The Cannabis Ecosystem In North America: Estimate And Forecast |
3.3 | The Optimistic Estimate For The U.S. Mrijuana Market |
3.4 | Tax Revenue Estimation For The U.S. Marijuana Market |
KEY STRATEGIES AND DEVELOPMENT IN THE NORTH AMERICAN CANNABIS MARKET (2013-2015)
4.1 | Introduction |
4.2 | Mergers And Acquisitions |
4.3 | Partnership, Collaboration & Joint Ventures |
4.4 | Product Launch |
4.5 | Business Expansion |
4.6 | Product Testing |
4.7 | Others |
MARKET DYNAMICS
5.1 | Introduction |
5.2 | Market Drivers |
5.2.1 | Automation Transforming The Cannabis Industry |
5.2.1.1 | Collaboration Of The Vending And Cannabis Industry |
5.2.1.2 | Automated Irrigation Systems And Fertigation |
5.2.2 | Increasing Adoption Of Information Technology In The Cannabis Industry |
5.2.3 | Rapid Adoption Of Cannabis For Medical Purposes |
5.2.4 | Multi-Faceted Applications Of Cannabis Derivatives |
5.2.5 | The Profitable Integration Of The Hydroponics And Cannabis Industry |
5.2.6 | The Combined Effect Of Vaper's Preference For Cannabis Oil And Increasing Adoption Of E-Cigarette |
5.3 | Market Challenges |
5.3.1 | Highly Volatile Regulatory Framework |
5.3.2 | Absence Of Market Leaders And Standards |
5.3.3 | The Issues Of Perception (Reputation Of Marijuana)/Marijuana Stigma |
5.3.4 | Federal Level Challenges |
5.3.4.1 | Lack Of Availability Of Bank Loans To Set Up Operations Due To Federal Banking Prerequisites |
5.3.4.2 | Federal Ban On Growing Industrial Hemp Forcing The Market Players To Import Raw Hemp |
5.3.5 | Highly Fragmented Supply Chain |
5.3.6 | Environmental Hazards |
NORTH AMERICA CANNABIS INDUSTRY ANALYSIS
6.1 | Porter’s Five Forces Analysis |
6.1.1 | Threat Of New Entrants |
6.1.1.1 | Entry Barriers (Government Policy And Capital Requirements) |
6.1.1.2 | Access To Distribution Channels |
6.1.1.3 | Economies Of Scale |
6.1.1.4 | Product Differentiation |
6.1.2 | Bargaining Power Of Buyers |
6.1.2.1 | Concentration Of Buyers |
6.1.2.2 | Importance Of Volume To Buyers |
6.1.2.3 | Threat Of Backward Integration |
6.1.2.4 | Buyer’s Information About Supplier’s Product |
6.1.2.5 | The Existence Of Black Market |
6.1.2.6 | Switching Cost |
6.1.2.7 | Legal And Regulatory Framework |
6.1.2.8 | Presence Of Substitutes |
6.1.3 | Bargaining Power Of Suppliers |
6.1.3.1 | Supplier Concentration |
6.1.3.2 | Threat Of Forward Integration |
6.1.3.3 | Product Differentiation |
6.1.3.4 | Switching Cost |
6.1.4 | Threat from substitutes |
6.1.4.1 | Buyer’s Propensity Towards Substitute |
6.1.4.2 | Consumer’s Switching Cost |
6.1.5 | Intensity Of Competitive Rivalry |
6.1.5.1 | Customer’s Loyalty Towards Brand |
6.1.5.2 | Intermittent Over Capacity |
6.1.5.3 | Product Differentiation |
6.1.5.4 | Industry Concentration |
6.1.5.5 | Entry Barriers |
6.1.5.6 | Exit Barriers |
6.2 | Value Chain Analysis |
6.2.1 | Introduction |
6.2.2 | Cannabis Growers/Producers |
6.2.3 | Pharmaceutical Companies |
6.2.3.1 | Research Facilities |
6.2.4 | Processing Industries |
6.2.5 | Packaging Industries |
6.2.6 | Dispensaries |
6.2.6.1 | Retail |
6.2.6.2 | Medical |
6.2.6.3 | Retail Outlets |
REGULATORY & LEGAL FRAMEWORK, CONSORTIUMS AND COMPLIANCES
7.1 | Introduction |
7.2 | Regulatory Bodies |
7.2.1 | Health Canada- Marijuana For Medical Purposes Regulations (MMPR) |
7.2.2 | Council On Responsible Cannabis Regulation (CRCR) |
7.2.3 | National Organization For The Reform Of Marijuana Laws (NORML) |
7.3 | Legal Framework |
7.3.1 | Federal Marijuana Law- Controlled Substance Act (CSA) |
7.3.2 | Marijuana Control Act 2014 |
7.3.3 | Hemp Farming Act 2015 |
7.4 | Compliances |
7.4.1 | Massachusetts Marijuana Compliance |
7.4.2 | Marijuana Enforcement Tracking Reporting Compliance (METRC) |
7.5 | Consortiums |
7.5.1 | American Herbal Products Association (AHPA) |
7.5.2 | Association Of Responsible Cannabis Public Companies (ARCPC) |
7.5.3 | Hemp Industries Association (HIA) |
7.5.4 | Drug Policy Alliance |
7.5.5 | International Association For Cannabinoid Medicine (IACM) |
7.5.6 | National Cannabis Industry Association (NCIA) |
7.5.7 | Canadian Medical Cannabis Industry Association (CMCIA) |
7.5.8 | California Cannabis Industry Association (CCIA) |
7.5.9 | Illinois Cannabis Industry Association |
7.5.10 | North American Industrial Hemp Council Inc. (NAIHC) |
7.5.11 | Canadian Hemp Trade Alliance (CHTA) |
7.5.12 | Kentucky Hemp Industries Association(KYHIA) |
MARKET SIZING – ESTIMATION, ANALYSIS & FORECAST BY DERIVATIVE
8.1 | Introduction |
8.1.1 | Market Statistics |
8.1.2 | Marijuana/Flowers |
8.1.2.1 | Market Statistics |
8.1.2.2 | Key Players |
8.1.3 | Industrial Hemp |
8.1.3.1 | Market Statistics |
8.1.3.2 | Key Players |
8.1.4 | Other Concentrates/Products |
8.1.4.1 | Kief |
8.1.4.2 | Hash |
8.1.4.3 | Hash Oil |
8.1.4.4 | Tinctures |
8.1.4.5 | Infusions |
MARKET SIZING- ESTIMATION, ANALYSIS & FORECAST BY APPLICATION
9.1 | Introduction |
9.1.1 | Market Statistics |
9.2 | Applications Of Marijuana |
9.2.1 | Medicinal Applications |
9.2.1.1 | Market Statistics |
9.2.1.2 | Key Players |
9.2.2 | Recreational Application Of Marijuana |
9.2.2.1 | Market Statistics |
9.3 | Applications Of Industrial Hemp |
9.3.1 | Food And Baby Care |
9.3.1.1 | Market Statistics |
9.3.2 | Clothing & Textile |
9.3.2.1 | Market Statistics |
9.3.3 | Other Hemp Products |
9.3.3.1 | Market Statistics |
MARKET SIZING ANALYSIS & FORECAST, BY MARKET DEMAND
10.1 | Introduction |
10.1.1 | Market Statistics |
10.2 | The U.S. |
10.2.1 | Market Statistics |
10.2.2 | California |
10.2.3 | Colorado |
10.2.4 | Washington |
10.2.5 | Arizona |
10.2.6 | Michigan |
10.2.7 | Oregon |
10.2.8 | Others |
10.2.9 | Legal & Regulatory Framework |
10.2.9.1 | Marijuana |
10.2.9.2 | Industrial Hemp |
10.2.10 | Key Market Players |
10.3 | Canada |
10.3.1 | Market Statistics |
10.3.2 | Key Market Players |
KEY MARKET PLAYERS PROFILE
11.1 | Growers |
11.1.1 | Canadian Cannabis Corporation |
11.1.1.1 | Company Overview |
11.1.1.2 | Financials |
11.1.1.2.1 | Overall Financials |
11.1.1.2.2 | Financial Summary |
11.1.1.3 | Key Developments |
11.1.2 | Plandai Biotechnology |
11.1.2.1 | Company Overview |
11.1.2.2 | Financials |
11.1.2.2.1 | Overall Financials |
11.1.2.2.2 | Financial Summary |
11.1.2.3 | Key Developments |
11.1.3 | Tweed Marijuana Inc. |
11.1.3.1 | Company Overview |
11.1.3.2 | Financials |
11.1.3.2.1 | Overall Financials |
11.1.3.2.2 | Financial Summary |
11.1.3.3 | Key Developments |
11.1.4 | Affinor Growers |
11.1.4.1 | Company Overview |
11.1.4.2 | Financials |
11.1.4.2.1 | Overall Financials |
11.1.4.2.2 | Financial Summary |
11.1.4.3 | Key Developments |
11.2 | Producers |
11.2.1 | Cannabis Sativa Inc. |
11.2.1.1 | Company Overview |
11.2.1.2 | Financials |
11.2.1.2.1 | Overall Financials |
11.2.1.2.2 | Financial Summary |
11.2.1.3 | Key Developments |
11.2.2 | Cannavest |
11.2.2.1 | Company Overview |
11.2.2.2 | Financials |
11.2.2.2.1 | Overall Financials |
11.2.2.2.2 | Financial Summary |
11.2.2.3 | Key Developments |
11.2.3 | Canna Brands Inc. |
11.2.3.1 | Company Overview |
11.2.3.2 | Financial Summary |
11.2.3.3 | Key Developments |
11.2.4 | Omnicanna Health Solutions |
11.2.4.1 | Company Overview |
11.2.4.2 | Financial Summary |
11.2.4.3 | Key Developments |
11.2.5 | Privateer Holdings, Inc. |
11.2.5.1 | Company Overview |
11.2.5.2 | Key Developments |
11.3 | Pharmaceutical & Research Companies |
11.3.1 | Arena Pharmaceuticals, Inc. |
11.3.1.1 | Company Overview |
11.3.1.2 | Financials |
11.3.1.2.1 | Overall Financials |
11.3.1.2.2 | Financial Summary |
11.3.1.3 | Key Developments |
11.3.2 | Cannabics Pharmaceuticals Inc. |
11.3.2.1 | Company Overview |
11.3.2.2 | Financial Summary |
11.3.2.3 | Key Developments |
11.3.3 | Cannabis Science, Inc. |
11.3.3.1 | Company Overview |
11.3.3.2 | Financials |
11.3.3.2.1 | Overall Financials |
11.3.3.2.2 | Financial Summary |
11.3.3.3 | Key Developments |
11.3.4 | GW Pharmaceuticals |
11.3.4.1 | Company Overview |
11.3.4.2 | Financials |
11.3.4.2.1 | Overall Financials |
11.3.4.2.2 | Revenue By Segment |
11.3.4.2.3 | Revenue By Region |
11.3.4.2.4 | Financial Summary |
11.3.4.3 | Key Developments |
11.3.5 | Hemp, Inc. |
11.3.5.1 | Company Overview |
11.3.5.2 | Financials |
11.3.5.2.1 | Overall Financials |
11.3.5.2.2 | Financial Summary |
11.3.5.3 | Key Developments |
11.3.6 | Insys Therapeutics |
11.3.6.1 | Company Overview |
11.3.6.2 | Financials |
11.3.6.2.1 | Overall Financials |
11.3.6.2.2 | Revenue By Segment |
11.3.6.2.3 | Financial Summary |
11.3.6.3 | Key Developments |
11.3.7 | Medical Marijuana Inc. |
11.3.7.1 | Company Overview |
11.3.7.2 | Financials |
11.3.7.2.1 | Overall Financials |
11.3.7.2.2 | Financial Summary |
11.3.7.3 | Key Developments |
11.3.8 | 22nd Century Group, Inc. |
11.3.8.1 | Company Overview |
11.3.8.2 | Financials |
11.3.8.2.1 | Overall Financials |
11.3.8.2.2 | Financial Summary |
11.3.8.3 | Key Developments |
11.3.9 | Otsuka Pharmaceutical Co. Ltd |
11.3.9.1 | Company Overview |
11.3.9.2 | Financials |
11.3.9.2.1 | Overall Financials |
11.3.9.2.2 | Revenue By Segment |
11.3.9.2.3 | Revenue By Region |
11.3.9.2.4 | Financial Summary |
11.3.9.3 | Key Developments |
11.3.10 | Sanofi Pharmaceuticals |
11.3.10.1 | Company Overview |
11.3.10.2 | Financials |
11.3.10.2.1 | Overall Financials |
11.3.10.2.2 | Financial Summary |
11.4 | Information Technology |
11.4.1 | Agrisoft Development Group |
11.4.1.1 | Company Overview |
11.4.1.2 | Key Developments |
11.4.2 | Endexx Corporation |
11.4.2.1 | Company Overview |
11.4.2.2 | Financials |
11.4.2.2.1 | Overall Financials |
11.4.2.3 | Key Developments |
11.4.3 | Green Technology Solutions Inc. (GTSO) |
11.4.3.1 | Company Overview |
11.4.3.2 | Financials |
11.4.3.2.1 | Overall Financials |
11.4.3.2.2 | Financial Summary |
11.4.3.3 | Key Developments |
11.4.4 | Quantum 9 |
11.4.4.1 | Company Overview |
11.4.4.2 | Financials |
11.4.4.3 | Key Developments |
11.5 | Equipment & Infrastructure |
11.5.1 | Advanced Cannabis Solutions |
11.5.1.1 | Company Overview |
11.5.1.2 | Financials |
11.5.1.2.1 | Overall Financials |
11.5.1.2.2 | Revenue By Segment |
11.5.1.2.3 | Financial Summary |
11.5.1.3 | Key Developments |
11.5.2 | Medbox, Inc. |
11.5.2.1 | Company Overview |
11.5.2.2 | Financials |
11.5.2.2.1 | Overall financials |
11.5.2.2.2 | Financial Summary |
11.5.2.3 | Key Developments |
11.5.3 | Surna, Inc. |
11.5.3.1 | Company Overview |
11.5.3.2 | Financials |
11.5.3.2.1 | Overall Financials |
11.5.3.2.2 | Financial Summary |
11.5.3.3 | Key Developments |
11.6 | Advisory Services And Education |
11.6.1 | Canna Grow Holdings |
11.6.1.1 | Company Overview |
11.6.1.2 | Financials |
11.6.1.2.1 | Overall Financials |
11.6.1.2.2 | Financial Summary |
11.6.1.3 | Key Developments |
11.7 | Others |
11.7.1 | Abattis Bioceuticals Corporation |
11.7.1.1 | Company Overview |
11.7.1.2 | Financials |
11.7.1.2.1 | Overall Financials |
11.7.1.2.2 | Financial Summary |
11.7.1.3 | Key Developments |
11.7.2 | Cannabis Therapy Corporation |
11.7.2.1 | Company Overview |
11.7.2.2 | Financials |
11.7.2.2.1 | Overall Financials |
11.7.2.2.2 | Financial Summary |
11.7.2.3 | Key Developments |
11.7.3 | Cannacare Docs |
11.7.3.1 | Company Overview |
11.8 | Application (APPS) Companies |
11.8.1 | Mass Roots |
11.8.1.1 | Company Overview |
11.8.2 | Eaze |
11.8.2.1 | Company Overview |
11.8.2.2 | Key Developments |
11.8.3 | Weedmaps |
11.8.3.1 | Company Overview |
11.8.4 | Meadow |
11.8.4.1 | Company Overview |
11.8.4.2 | Key Developments |
11.8.5 | Nestdrop |
11.8.5.1 | Company Overview |
11.8.5.2 | Key Developments |
11.8.6 | Leafly |
11.8.6.1 | Company Overview |
11.8.7 | Grassp |
11.8.7.1 | Company Overview |
11.8.8 | Dave |
11.8.8.1 | Company Overview |
11.8.9 | Frweed Pro |
11.8.9.1 | Company Overview |
LIST OF TABLES
TABLE 1 | TIMELINE OF MEDICAL MARIJUANA LEGALIZATION |
TABLE 2 | THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020 |
TABLE 3 | FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE |
TABLE 4 | COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM |
TABLE 5 | CANNABIS SATIVA VS CANNABIS INDICA |
TABLE 6 | NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020 |
TABLE 7 | NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020 |
TABLE 8 | NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020 |
TABLE 9 | NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 10 | NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020 |
TABLE 11 | NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020 |
TABLE 12 | NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 13 | NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020 |
TABLE 14 | DISEASES & CURE BY CANNABIS |
TABLE 15 | INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA |
TABLE 16 | NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020 |
TABLE 17 | NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 18 | NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 19 | NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 20 | NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 21 | NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020 |
TABLE 22 | NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020 |
TABLE 23 | THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020 |
TABLE 24 | THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020 |
TABLE 25 | THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020 |
TABLE 26 | MARIJUANA LEGALIZATION DETAILS BY STATES |
TABLE 27 | MARIJUANA POSESSION DETAILS |
TABLE 28 | INDUSTRIAL HEMP POSESSION DETAILS |
TABLE 29 | CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020 |
TABLE 30 | CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020 |
LIST OF FIGURES
FIGURE 1 | BIS RESEARCH METHODOLOGY |
FIGURE 2 | THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY |
FIGURE 3 | CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020 |
FIGURE 4 | CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020 |
FIGURE 5 | CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020 |
FIGURE 6 | THE CANNABIS ECOSYSTEM WITH KEY PLAYERS |
FIGURE 7 | AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014) |
FIGURE 8 | KEY MERGERS & ACQUISITIONS (2013-15) |
FIGURE 9 | KEY PARTNERSHIPS & COLLABORATIONS (2013-15) |
FIGURE 10 | KEY PRODUCT LAUNCHES (2013-15) |
FIGURE 11 | KEY BUSINESS EXPANSION ACTIVITIES (2013-15) |
FIGURE 12 | KEY PRODUCT TESTING ACTIVITIES (2013-15) |
FIGURE 13 | OTHER KEY DEVELOPMENTS (2013-15) |
FIGURE 14 | BENEFITS OF USING CANNABIS VENDING MACHINES |
FIGURE 15 | WHY CANNABIS INDUSTRY NEEDS STANDARDS |
FIGURE 16 | NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER’S FIVE FORCES |
FIGURE 17 | NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS |
FIGURE 18 | FEATURE OF MMPR |
FIGURE 19 | MISSION OF CRCR |
FIGURE 20 | MISSION OF NORML |
FIGURE 21 | PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA |
FIGURE 22 | ARCPC MISSION |
FIGURE 23 | HIA MISSION |
FIGURE 24 | DPA MISSION |
FIGURE 25 | STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY |
FIGURE 26 | KEY FEATURES OF NCIA |
FIGURE 27 | CMCIA MISSION |
FIGURE 28 | NAIHC MISSION |
FIGURE 29 | KEY VARIETIES OF CANNABIS STRAINS |
FIGURE 30 | THE PSYCHOACTIVE EFFECTS OF MARIJUANA |
FIGURE 31 | MEDICAL BENEFITS OF MARIJUANA |
FIGURE 32 | INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP |
FIGURE 33 | APPLICATIONS OF CANNABIS PLANT |
FIGURE 34 | NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 35 | NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 36 | APPLICATIONS OF INDUSTRIAL HEMP |
FIGURE 37 | NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 38 | NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 39 | NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020 |
FIGURE 40 | LEGALIZATION STATUS OF CANNABIS |
FIGURE 41 | CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION) |
FIGURE 42 | PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION) |
FIGURE 43 | TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION) |
FIGURE 44 | AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 45 | CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 46 | CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 47 | ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 48 | CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 49 | GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION) |
FIGURE 50 | REVENUE BY SEGMENT 2012-14 |
FIGURE 51 | REVENUE BY REGION2012-2014 |
FIGURE 52 | HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION) |
FIGURE 53 | INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 54 | MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 55 | 22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 56 | OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION) |
FIGURE 57 | SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION) |
FIGURE 58 | ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION) |
FIGURE 59 | GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION) |
FIGURE 60 | ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION) |
FIGURE 61 | MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION) |
FIGURE 62 | SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION) |
FIGURE 63 | CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION) |
FIGURE 64 | ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION) |
FIGURE 65 | CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION) |
North America Cannabis Market
Focus on Application, Derivative, and Region – Estimation & Forecast, 2015-2020